AI Verdict
ABT has stronger fundamentals based on our AI analysis.
ABBV vs ABT Fundamental Comparison
| Metric | ABBV | ABT |
|---|---|---|
| Revenue | $15.0B | $11.2B |
| Net Income | $695.0M | $1.1B |
| Net Margin | 4.6% | 9.6% |
| ROE | N/A | 2.1% |
| ROA | 0.5% | 1.0% |
| Current Ratio | 0.80x | 1.39x |
| Debt/Equity | N/A | 0.57x |
| EPS | $0.39 | $0.61 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABBV vs ABT: Frequently Asked Questions
Is ABBV or ABT the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ABT has stronger fundamentals. ABBV is graded C (78% confidence) while ABT is graded B (74% confidence). This is not investment advice.
How does ABBV compare to ABT fundamentally?
AbbVie Inc. has ROE of N/A vs ABBOTT LABORATORIES's 2.1%. Net margins are 4.6% vs 9.6% respectively.
Which stock pays higher dividends, ABBV or ABT?
ABBV has a dividend yield of N/A or no dividend while ABT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABBV or ABT for long term?
For long-term investing, consider that ABBV has a C grade with 78% confidence, while ABT has a B grade with 74% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABBV vs ABT?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABBV vs ABT, the AI consensus favors ABT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.